OrbiMed
Healthcare
OrbiMed-backed Eurolife acquires Teva's European intravenous infusion plant
Indian pharmaceuticals firm Eurolife Healthcare Pvt. Ltd on Friday said it has acquired the European intravenous infusions plant of Israel-based ......
General
GVK dials NIIF, ADIA to raise funds for Mumbai airport; PE firms eye Bharat Serums
Infrastructure company GVK is in talks with the National Investment and Infrastructure Fund and Abu Dhabi Investment Authority (ADIA) to ......
Healthcare
OrbiMed to invest more capital in latest India portfolio firm
Healthcare-focussed private equity investor OrbiMed has pumped additional capital into its newest India portfolio company and is likely to infuse ......
Healthcare
Healthcare PE firm OrbiMed invests in Indian enzymes maker
Healthcare-focussed private equity firm OrbiMed has added a second company to its portfolio in the space of four months, an ......
Healthcare
OrbiMed backs pharma firm floated by former Alkem CEO
Healthcare-focussed private equity firm OrbiMed has struck its first new deal in India this year by investing in a pharmaceutical ......
Healthcare
InvAscent topping up oversubscribed healthcare PE fund
Healthcare private equity firm InvAscent is set to add more money to its India-focused third fund before hitting the final ......
Healthcare
Tata Capital targets bigger corpus for second healthcare private equity fund
Tata Capital Ltd has formally kicked off a process to mobilise capital for its second healthcare private equity fund, targeting ......
General
Amazon in talks to buy into Spencer's Retail; PVR eyes Wave Cinemas
Online retailer Amazon is in discussions to pick up a minority stake RP-Sanjiv Goenka Group’s retail chain Spencer’s Retail, a ......
Healthcare
Asian Institute of Medical Sciences raises funding from CDC
Blue Sapphire Healthcare Pvt. Ltd, which operates super-specialty hospital Asian Institute of Medical Sciences in Faridabad, has raised $21 million ......
Healthcare
OrbiMed injects more funds into Vivimed's bulk-drugs arm
Pharmaceuticals company Vivimed Labs Ltd said it has received $7.5 million (Rs 47.7 crore) more for its active pharmaceutical ingredient ......